Beta Bionics, Inc. ($BBNX)
Filing Information
| Accession Number | 0002048500-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
168,918
Total Value
$13,152.74
P&L
+inf% (+$1,796,037.80)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Product Officer | Common Stock | โ | Feb 27, 2026 | Grant/Award | 109,105 | $0.00 | $0.00 | 189,857 | Direct | โ | View Details | |
Chief Product Officer | Common Stock | โ | Mar 2, 2026 | Sale | 1,064 | $12.36 | $13,152.74 | 188,793 | Direct | โ | View Details | |
Chief Product Officer | Employee Stock Option (right to buy) | Derivative | Feb 27, 2026 | Grant/Award | 58,749 | $0.00 | $0.00 | 58,749 | Direct | โ | View Details |